Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  SpineGuard    ALSGD   FR0011464452


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SpineGuard : Expands Its Intellectual Property

share with twitter share with LinkedIn share with facebook
07/10/2020 | 03:01am EDT

  • Original utilization of ultrasounds to complement the DSG guidance technology
  • X-Ray free determination of entry point and trajectory in bone
  • Grant of two new patents in Japan and China

Regulatory News:

SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces today the grant of two new patents in Japan and China.

The invention presented in the patents consists of implementing ultrasound technology in an original manner in order to determine without X-Rays and from the surface of the bone, the position of the entry point and the optimal trajectory for a bone drilling instrument.

Stéphane Bette, Deputy CEO and co-founder of SpineGuard, said: For several years SpineGuard has been inventing and assembling complementary technical solutions for positioning instruments and implants precisely and safely in bone, while alleviating the systematic dangerous recourse to X-Ray imaging. The invention that is validated here has the potential to complement our DSG sensing technology. Indeed, it may allow the surgeon, or the surgical robot, to find from the surface of the bone the position of the entry point as well as the optimal trajectory. Once the instrument has penetrated the entry point, our DSG sensor in the bone will optimize the prevention of breaches. China and Japan are the second and third largest markets for medical devices today, they are therefore a significant stake in terms of intellectual property. Our IP portfolio continues to strengthen and feeds our discussions toward structuring strategic alliances.

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 75,000 surgical procedures worldwide. Fifteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the « smart » pedicle screw launched late 2017 and is broadening the scope of applications in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.

For further information, visit www.spineguard.com


The SpineGuard securities may not be offered or sold in the United States as they have not been and will not be registered under the Securities Act or any United States state securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an announcement and not a prospectus, and the information contained herein does and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the United States in which such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

© Business Wire 2020

share with twitter share with LinkedIn share with facebook
All news about SPINEGUARD
10/20SPINEGUARD : strengthens its intellectual property with a new patent granted in ..
10/20SPINEGUARD : Strengthens Its Intellectual Property With a New Patent Granted in ..
10/1616 OCTOBER 2020 – 10H45 CET : SpineGuard morning note by BioStrategic Rese..
10/15SPINEGUARD : reports third-quarter 2020 revenue
10/15SPINEGUARD : Reports Third-quarter 2020 Revenue
10/15SPINEGUARD : 3rd quarter earnings
09/1616 SEPTEMBER 2020 – 10H45 CET : SpineGuard morning note by BioStrategic Re..
09/15SPINEGUARD : Reports Six-Month 2020 Financial Results
09/15SPINEGUARD : Reports Six-Month 2020 Financial Results
09/15SPINEGUARD : Half-year results
More news
Sales 2019 6,83 M 7,96 M 7,96 M
Net income 2019 -0,69 M -0,80 M -0,80 M
Net Debt 2019 4,80 M 5,59 M 5,59 M
P/E ratio 2019 -3,28x
Yield 2019 -
Capitalization 2,98 M 3,48 M 3,48 M
EV / Sales 2018 1,38x
EV / Sales 2019 0,99x
Nbr of Employees 14
Free-Float 99,5%
Duration : Period :
SpineGuard Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPINEGUARD
Short TermMid-TermLong Term
Income Statement Evolution
Pierre Jérôme Chairman & Chief Executive Officer
Manuel Lanfossi Chief Financial & Administrative Officer
Thibault Chandanson Director-Research & Development
Stéphane Bette Director & Deputy Chief Executive Officer
Maurice Bourlion Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI INTECC CO., LTD.1.09%8 131
GETINGE AB-0.11%5 302